Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SOPH

SOPHiA Genetics SA

Oct 28 • 04:00PM ET

4.09

-0.11 -2.62 %

Healthcare • Health Information Services • Switzerland • NASD

Peers: ILMN QGEN GH TXG OMIC CRSP EDIT NTLA DNA PACB

| Held by: ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.10	Insider Own	22.52%	Shs Outstand	67.58M	Perf Week	-2.62%
Market Cap	276.40M	Forward P/E	-	EPS next Y	-0.82	Insider Trans	0.00%	Shs Float	52.36M	Perf Month	-7.67%
Enterprise Value	245.39M	PEG	-	EPS next Q	-0.23	Inst Own	24.46%	Short Float	0.04%	Perf Quarter	28.62%
Income	-73.40M	P/S	3.97	EPS this Y	-10.26%	Inst Trans	-11.46%	Short Ratio	0.24	Perf Half Y	29.43%
Sales	69.69M	P/B	3.60	EPS next Y	21.24%	ROA	-40.92%	Short Interest	0.02M	Perf YTD	33.22%
Book/sh	1.13	P/C	2.91	EPS next 5Y	14.36%	ROE	-74.09%	52W High	4.92 -16.87%	Perf Year	21.01%
Cash/sh	1.40	P/FCF	-	EPS past 3/5Y	6.40% -12.32%	ROIC	-53.18%	52W Low	2.58 58.53%	Perf 3Y	92.02%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	17.23% 20.77%	Gross Margin	67.78%	Volatility	8.84% 8.75%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.52	EPS Y/Y TTM	-7.49%	Oper. Margin	-96.96%	ATR (14)	0.34	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.21	Sales Y/Y TTM	7.31%	Profit Margin	-105.32%	RSI (14)	50.07	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.39	EPS Q/Q	-44.43%	SMA20	-3.89%	Beta	1.08	Target Price	7.00
Payout	-	Debt/Eq	0.83	Sales Q/Q	15.91%	SMA50	7.42%	Rel Volume	1.04	Prev Close	4.20
Employees	423	LT Debt/Eq	0.80	Earnings	Nov 04 BMO	SMA200	19.87%	Avg Volume	89.00K	Price	4.09
IPO	Jul 23, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-54.21% 4.76%	Trades		Volume	92,780	Change	-2.62%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-18-24	Initiated	Craig Hallum	Buy	$11
Aug-07-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$10 → $5
Jun-27-24	Initiated	Guggenheim	Buy	$6
Nov-29-23	Initiated	RBC Capital Mkts	Outperform	$8
Jul-05-23	Resumed	JP Morgan	Overweight	$10
Jan-03-23	Initiated	BTIG Research	Buy	$6
Nov-23-22	Initiated	Credit Suisse	Neutral	$2
Oct-15-21	Resumed	Cowen	Outperform
Aug-17-21	Initiated	Morgan Stanley	Overweight	$24
Aug-17-21	Initiated	JP Morgan	Overweight	$23
Aug-17-21	Initiated	Credit Suisse	Outperform	$22
Aug-17-21	Initiated	Cowen	Outperform

Show Previous Ratings

Oct-21-25 08:00AM	SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 (PR Newswire)
Oct-20-25 09:03AM	Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy? (Zacks)
Oct-16-25 11:00AM	A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan (PR Newswire)
04:01AM	SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology (PR Newswire)
Sep-23-25 08:01AM	Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy (PR Newswire)
08:00AM	Loading…
Sep-22-25 08:00AM	SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer (PR Newswire) +18.37%
Sep-08-25 05:36AM	Jessa Ziekenhuis to adopt SOPHiA GENETICS platform for cancer care (Hospital Management)
Sep-05-25 04:00AM	SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology (PR Newswire)
Aug-19-25 09:33AM	Strategic Partnerships Power Tempus AI's Healthcare Expansion (Zacks)
Aug-13-25 03:00PM	Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold? (Zacks)
Aug-06-25 11:01AM	Sophia Genetics SA (SOPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -7.95%
Aug-05-25 06:45AM	SOPHiA GENETICS Reports Second Quarter 2025 Results (PR Newswire)
06:40AM	SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes (PR Newswire)
Aug-04-25 10:07AM	Sophia Genetics SA (SOPH) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-01-25 03:00PM	Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy? (Zacks)
08:00AM	Loading…
Jul-22-25 08:00AM	SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025 (PR Newswire)
Jul-17-25 03:00PM	TEM Shares Surge on New AI Breakthrough: Should Investors Jump In? (Zacks)
Jun-09-25 03:00PM	Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? (Zacks) -8.63%
May-15-25 03:00PM	After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? (Zacks)
May-07-25 03:06AM	Sophia Genetics SA (SOPH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ... (GuruFocus.com)
May-06-25 07:55AM	SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:45AM	SOPHiA GENETICS Reports First Quarter 2025 Results (PR Newswire)
May-05-25 10:19AM	Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q1 2025 Result (GuruFocus.com)
Apr-28-25 03:00PM	Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? (Zacks)
12:23PM	SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR (PR Newswire)
Apr-25-25 04:49AM	The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS (Zacks)
Apr-24-25 03:00PM	Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal? (Zacks)
Apr-22-25 08:00AM	SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025 (PR Newswire)
Apr-08-25 02:00AM	Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM Platform and its Liquid Biopsy Capabilities (PR Newswire)
Apr-01-25 03:00PM	Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? (Zacks)
12:00PM	Loading…
Mar-21-25 12:00PM	SOPHiA GENETICS (SOPH) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-18-25 09:00AM	SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC (PR Newswire)
Mar-05-25 02:04AM	Sophia Genetics SA (SOPH) Q4 2024 Earnings Call Highlights: Record Customer Growth Amidst ... (GuruFocus.com)
Mar-04-25 07:55AM	SOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -13.17%
06:45AM	SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results (PR Newswire)
Mar-03-25 07:21AM	What To Expect From Sophia Genetics SA (SOPH) Q4 2024 Earnings (GuruFocus.com)
Feb-24-25 04:03AM	Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy Testing (PR Newswire)
Feb-18-25 08:30AM	SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025 (PR Newswire) +11.22%
Jan-28-25 08:59AM	SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities (PR Newswire)
Nov-21-24 05:30AM	SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024 (PR Newswire)
Nov-06-24 06:59AM	SOPHiA GENETICS Faces Financial Challenges Amid Losses (TipRanks) -9.33%
02:08AM	Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
12:10AM	Q3 2024 Sophia Genetics SA Earnings Call (Thomson Reuters StreetEvents)
Nov-05-24 06:32AM	SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer (PR Newswire)
06:30AM	SOPHiA GENETICS Reports Third Quarter 2024 Results (PR Newswire)
Nov-04-24 09:57AM	SOPHiA GENETICS SA (SOPH): A Bull Case Theory (Insider Monkey)
07:13AM	Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-22-24 06:45AM	SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024 (PR Newswire)
Sep-14-24 09:00AM	SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 (PR Newswire)
Sep-12-24 07:00AM	SOPHiA GENETICS Announces Poster Presentations at ESMO 2024 (PR Newswire)
04:00AM	SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024 (PR Newswire)
Sep-11-24 07:33AM	Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout (Medical Device Network) +8.70%
Sep-10-24 10:28AM	SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing (PR Newswire)
Sep-05-24 08:30AM	SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 (PR Newswire) +5.59%
Sep-04-24 06:00AM	SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024 (PR Newswire)
Aug-28-24 01:30PM	SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference (PR Newswire) +5.26%
Aug-14-24 09:13AM	Sophia Genetics secures CE mark for DDM analytics platform under EUs IVDR (Medical Device Network)
03:00AM	SOPHiA DDM Platform Certified Under IVDR (PR Newswire)
Aug-12-24 09:35AM	SOPHiA GENETICS (SOPH) Loses -30.47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Aug-09-24 12:00PM	What Makes SOPHiA GENETICS (SOPH) a New Buy Stock (Zacks)
Aug-06-24 07:55AM	SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:45AM	SOPHiA GENETICS Reports Second Quarter 2024 Results (PR Newswire)
Jul-29-24 10:30AM	SOPHiA GENETICS Announces L'hpital Universitaire Avicenne is Live on SOPHiA DDM (PR Newswire)
Jul-24-24 11:59AM	SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix (PR Newswire)
Jul-23-24 06:45AM	SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024 (PR Newswire)
Jul-05-24 04:32AM	Indias Dhiti Omics deploys SOPHiA DDM platform for solid tumour testing (Medical Device Network)
Jul-04-24 02:30AM	India-Based Dhiti Omics is Now Live on SOPHiA DDM (PR Newswire)
Jun-24-24 09:47AM	SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting (GlobeNewswire)
02:00AM	SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application (PR Newswire)
Jun-13-24 06:00AM	SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM Platform (PR Newswire)
May-30-24 12:39PM	SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care (PR Newswire)
May-29-24 10:00AM	SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities (PR Newswire)
May-20-24 10:02AM	SOPHiA GENETICS Announces Instituto Mrio Penna as New Customer (PR Newswire)
May-16-24 06:02AM	Klinikum Klagenfurt am Wrthersee is Live with SOPHiA GENETICS (PR Newswire)
May-13-24 12:22PM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 10:53AM	SOPH Stock Earnings: Sophia Genetics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:55AM	Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a Bet (Zacks)
06:45AM	SOPHiA GENETICS Reports First Quarter 2024 Results (GlobeNewswire)
Apr-30-24 07:05AM	SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-23-24 10:29AM	SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024 (GlobeNewswire)
06:37AM	Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering (MT Newswires)
05:05AM	SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa (PR Newswire)
Apr-17-24 06:05AM	SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD) (PR Newswire)
Apr-04-24 01:00AM	SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership (PR Newswire)
Apr-02-24 10:00AM	Laboratorio Barnafi-Krause is Live on SOPHiA DDM (PR Newswire)
Mar-20-24 10:00AM	SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada (PR Newswire) +5.78%
Mar-15-24 06:00AM	SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration (PR Newswire) +5.94%
Mar-07-24 12:07PM	SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Mar-06-24 08:31AM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.54%
03:15AM	Q4 2023 Sophia Genetics SA Earnings Call (Thomson Reuters StreetEvents)
Mar-05-24 06:45AM	SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-22-24 08:45AM	SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference (GlobeNewswire)
Feb-20-24 10:46AM	SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024 (GlobeNewswire) +10.68%
Feb-07-24 06:51AM	SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain (PR Newswire)
Jan-25-24 10:50AM	SOPHiA GENETICS Supports Genetic Testing in Brazil (PR Newswire)
Jan-18-24 03:00PM	SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio (PR Newswire)
Jan-14-24 11:00PM	SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India (PR Newswire)
Jan-10-24 05:15PM	SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-08-24 09:08AM	Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics (PR Newswire)
Dec-21-23 07:00AM	Hpital Saint-Louis Implements SOPHiA DDM Platform to Further Research of Myeloid Disorders (PR Newswire)

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
PHILIPPE MENU	Officer	Oct 20 '25	Proposed Sale	4.31	1,286	5,543	Oct 20 04:20 PM
MANUELA VALENTE	Officer	Oct 03 '25	Proposed Sale	4.47	3,866	17,281	Oct 03 04:38 PM
ROSS J MUKEN	Officer	Oct 03 '25	Proposed Sale	4.47	13,486	60,282	Oct 03 04:37 PM
DAAN GUIDO MARIA VAN WELL	Officer	Oct 03 '25	Proposed Sale	4.47	6,160	27,535	Oct 03 04:37 PM
ZHENYU XU	Officer	Oct 03 '25	Proposed Sale	4.47	6,833	30,544	Oct 03 04:36 PM
JURGI CAMBLONG	Director	Sep 29 '25	Proposed Sale	4.13	83,558	345,095	Sep 29 04:35 PM
JURGI CAMBLONG	Director	Sep 26 '25	Proposed Sale	3.43	10,415	35,723	Sep 26 04:26 PM
VINCENT OSSIPOW	Director	Sep 23 '25	Proposed Sale	3.93	21,000	82,530	Sep 23 04:35 PM
JURGI CAMBLONG	Director	Aug 19 '25	Proposed Sale	3.49	40,829	142,493	Aug 19 04:28 PM
PHILIPPE MENU	Officer	Aug 19 '25	Proposed Sale	3.49	6,833	23,847	Aug 19 04:27 PM
ZHENYU XU	Officer	Jul 03 '25	Proposed Sale	3.04	6,939	21,095	Jul 03 01:24 PM
DAAN GUIDO MARIA VAN WELL	Officer	Jul 03 '25	Proposed Sale	3.04	6,279	19,088	Jul 03 01:24 PM
MANUELA VALENTE	Officer	Jul 03 '25	Proposed Sale	3.04	3,930	11,947	Jul 03 01:23 PM
KATHY L HIBBS	Director	Jun 30 '25	Proposed Sale	3.09	10,000	30,900	Jun 30 04:19 PM
VINCENT OSSIPOW	Director	Jun 20 '25	Proposed Sale	3.04	18,443	56,067	Jun 20 04:23 PM
ROSS J MUKEN	Officer	Jun 20 '25	Proposed Sale	3.04	14,509	44,107	Jun 20 04:23 PM
JURGI CAMBLONG	Director	May 19 '25	Proposed Sale	2.96	43,135	127,680	May 19 04:21 PM
PHILIPPE MENU	Officer	May 19 '25	Proposed Sale	2.96	7,148	21,158	May 19 04:21 PM
MANUELA VALENTE	Officer	Mar 24 '25	Proposed Sale	3.02	7,186	21,702	Mar 24 04:24 PM
ZHENYU XU	Officer	Mar 24 '25	Proposed Sale	3.02	12,056	36,409	Mar 24 04:23 PM
DAAN GUIDO MARIA VAN WELL	Officer	Mar 24 '25	Proposed Sale	3.02	10,781	32,559	Mar 24 04:23 PM
ROSS J MUKEN	Officer	Mar 19 '25	Proposed Sale	3.21	15,303	49,123	Mar 19 04:22 PM
PHILIPPE MENU	Officer	Feb 19 '25	Proposed Sale	4.46	18,738	83,571	Feb 19 04:35 PM
JURGI CAMBLONG	Director	Feb 19 '25	Proposed Sale	4.46	90,471	403,501	Feb 19 04:26 PM
PHILIPPE MENU	Officer	Jan 27 '25	Proposed Sale	4.20	7,500	31,500	Jan 27 04:26 PM
JURGI CAMBLONG	Director	Jan 27 '25	Proposed Sale	4.20	28,500	119,700	Jan 27 04:25 PM
JURGI CAMBLONG	Director	Jan 24 '25	Proposed Sale	4.33	18,758	81,222	Jan 24 04:18 PM
MANUELA VALENTE	Officer	Dec 24 '24	Proposed Sale	3.31	3,423	11,330	Dec 26 08:14 AM
JURGI CAMBLONG	Director	Dec 24 '24	Proposed Sale	3.31	40,343	133,535	Dec 26 08:14 AM
ZHENYU XU	Officer	Dec 24 '24	Proposed Sale	3.31	6,152	20,363	Dec 26 08:14 AM
DAAN GUIDO MARIA VAN WELL	Officer	Dec 24 '24	Proposed Sale	3.31	5,815	19,248	Dec 26 08:14 AM
ROSS J MUKEN	Officer	Dec 19 '24	Proposed Sale	3.40	6,762	22,991	Dec 19 04:19 PM
PHILIPPE MENU	Officer	Dec 19 '24	Proposed Sale	3.40	5,544	18,850	Dec 19 04:19 PM
ZHENYU XU	Officer	Dec 13 '24	Proposed Sale	3.29	4,000	13,140	Dec 13 04:27 PM
Zhenyu Xu	Officer	Nov 19 '24	Proposed Sale	3.30	792	2,614	Nov 19 02:52 PM
Ross Muken	Officer	Nov 19 '24	Proposed Sale	3.30	1,485	4,900	Nov 19 02:50 PM
Philippe Menu	Officer	Nov 19 '24	Proposed Sale	3.30	792	2,614	Nov 19 02:49 PM
Manuela Valente	Officer	Nov 19 '24	Proposed Sale	3.30	495	1,634	Nov 19 02:48 PM
Jurgi Camblong	Director	Nov 19 '24	Proposed Sale	3.30	5,839	19,269	Nov 19 02:46 PM
Daan Guido Maria Van Well	Officer	Nov 19 '24	Proposed Sale	3.30	890	2,937	Nov 19 02:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SOPH

SOPHiA Genetics SA

Upgrade your FINVIZ experience